Latest / The Well-Built Life / Sunlight’s Secret: How Infrared Affects Mitochondria
Transcript
- 0:00Speaker 1: Hey everyone, welcome back to The Well-Built Life. I am
- 0:03Speaker 1: Rachel Caldwell, alongside Thomas Bennett, and we are so glad
- 0:07Speaker 1: you are tuning in. We are here to cut through
- 0:09Speaker 1: the noise, skip the intense jargon and extreme rules, and
- 0:13Speaker 1: share simple practical habits that help you feel stronger, healthier,
- 0:17Speaker 1: and more balanced every single day. Grab a drink, get comfortable,
- 0:22Speaker 1: and let's dive in. Welcome back to The Well-Built Life.
- 0:25Speaker 1: Today we are diving deep into some groundbreaking research that
- 0:29Speaker 1: has the potential to change how we think about energy
- 0:31Speaker 1: production in our bodies from 2005 to 2018. And now
- 0:37Speaker 1: in 2025, we have a fascinating journey with researchers like Dr.
- 0:42Speaker 1: Roger Schwelt, Dr. Robert Fosbury, and their team. Let's start
- 0:46Speaker 1: with the earliest findings. How can you sum up the
- 0:49Speaker 1: initial findings from 2005? Absolutely, Rachel.
- 0:54Speaker 2: The 2005 studies were the first to show that infrared light,
- 0:57Speaker 2: particularly at 1,600 nanometers, significantly boosted mitochondrial ATP production. It
- 1:05Speaker 2: was a compelling hint that light might have a much
- 1:07Speaker 2: deeper role in cellular function than we previously assumed. So,
- 1:11Speaker 2: in 2005, they were just scratching the surface. Right.
- 1:15Speaker 1: And that's the crucial nuance here. It wasn't just about
- 1:18Speaker 1: getting a boost, but understanding what's happening at the molecular level.
- 1:23Speaker 1: The mitochondrial electron transport chain must be playing a significant role. So,
- 1:29Speaker 1: what led Schwelt and company to question the traditional hypotheses
- 1:33Speaker 1: in 2018?
- 1:34Speaker 2: Well, let's back up a bit. The 2018 study by
- 1:38Speaker 2: Schwelt et al. really shook things up. They found that
- 1:41Speaker 2: different near-infrared wavelengths, like 810 nm, 750 nm, and 950 nm,
- 1:50Speaker 2: could both increase and decrease mitochondrial complex activity. This suggested
- 1:55Speaker 2: a more complex interaction than the simple photochemical hypothesis. Essentially,
- 2:00Speaker 2: they were uncovering a sophisticated mechanism at work, which led
- 2:04Speaker 2: us to explore more deeply.
- 2:06Speaker 1: Exactly. Which brings up an interesting contradiction. The 2018 study
- 2:11Speaker 1: seems to challenge the straightforward idea that light just boosts
- 2:16Speaker 1: ATP production. This complexity... raises questions about how different wavelengths
- 2:21Speaker 1: interact with the mitochondria. What do you think about that?
- 2:25Speaker 2: That's a good point, Rachel. The complexity lies in the mechanism.
- 2:30Speaker 2: Rather than direct activation, the research now suggests that infrared
- 2:34Speaker 2: light modulates the rate-limiting metabolic steps through a Marcus electron
- 2:39Speaker 2: transfer framework. This means it changes the vibrational state of
- 2:43Speaker 2: surrounding molecules, influencing the probability of electron transfer. It's a
- 2:48Speaker 2: much more nuanced and indirect interaction than what we might
- 2:51Speaker 2: have initially expected.
- 2:52Speaker 1: Right. And this new framework opens up a whole new
- 2:55Speaker 1: world of possibilities. So, in their 2025 preprint, they propose
- 3:01Speaker 1: that sunlight's broad spectrum of wavelengths can interact with multiple
- 3:05Speaker 1: vibrational modes, impacting ATP synthesis. This sounds like a major
- 3:10Speaker 1: shift in our understanding. Can you walk us through the
- 3:14Speaker 1: key findings there? That's wild when you look at the
- 3:16Speaker 1: raw numbers. For example, the metabolic scaling analysis they perform
- 3:21Speaker 1: suggests that ambient sunlight is sufficient to influence metabolic kinetics
- 3:25Speaker 1: across the biosphere. This means the impact of these photons
- 3:29Speaker 1: isn't just local, but could have widespread implications for cellular
- 3:33Speaker 1: energy production. Wait, but how does that actually play out
- 3:37Speaker 1: in practice? How might this shift the field of photobiomodulation research?
- 3:42Speaker 2: A great question, Rachel. This could revolutionize how we think
- 3:46Speaker 2: about light therapy and mitochondrial health. For practitioners and researchers,
- 3:51Speaker 2: it means we need to refine our techniques and technologies
- 3:54Speaker 2: to target the specific wavelengths that can modulate these steps.
- 3:58Speaker 2: For example, developing targeted phototherapy for metabolic disorders could become
- 4:03Speaker 2: more precise and effective.
- 4:05Speaker 1: Exactly. And what about the broader stakeholder areas? Who are
- 4:10Speaker 1: the key individuals and organizations that might be impacted The.
- 4:15Speaker 2: Primary stakeholders include photobiomodulation researchers and practitioners, medical professionals, particularly
- 4:24Speaker 2: those focused on mitochondrial health and metabolic disorders, lighting and
- 4:29Speaker 2: technology innovators looking to optimize light for health applications, and
- 4:34Speaker 2: astrophysicists interested in the biophysical properties of solar radiation and
- 4:39Speaker 2: its broader implications for living systems. It's a multidisciplinary field
- 4:44Speaker 2: that's only going to grow.
- 4:45Speaker 1: That's a lot to consider. So, as we conclude this section,
- 4:51Speaker 1: what are the key takeaways we should remember from this research?
- 4:55Speaker 2: Well, the main takeaways are that the traditional photochemical hypothesis
- 4:59Speaker 2: might need revisiting, and the indirect vibrational interaction of infrared
- 5:04Speaker 2: light with mitochondrial function is a critical new angle. And
- 5:09Speaker 2: we need to continue exploring the specific wavelengths and their
- 5:12Speaker 2: effects to fully harness the potential of photobiomodulation for improving
- 5:16Speaker 2: human health.
- 5:17Speaker 1: So, let's dive into the heart of this mechanism. Specifically,
- 5:23Speaker 1: how do these infrared wavelengths interact with mitochondrial vibrations to
- 5:27Speaker 1: affect ATP production? And what does this mean for our
- 5:31Speaker 1: understanding of PBM?
- 5:32Speaker 2: Right, because the core of the Schwelte Dadaal S-theory challenges
- 5:36Speaker 2: the traditional notion of PBM, which proposed a direct photochemical interaction. Instead,
- 5:43Speaker 2: they suggest an indirect mechanism involving vibrational states. For instance,
- 5:48Speaker 2: consider the 1,600 nanometers light's impact. It's not just about
- 5:53Speaker 2: activating cytochrome C oxidase directly, it's about increasing its vibrational activity,
- 5:59Speaker 2: which in turn leads to more efficient electron transfer. Absolutely.
- 6:03Speaker 2: It's like the old saw about changing the rules of
- 6:06Speaker 2: the game halfway through, Schwelt et al. Propose that the
- 6:09Speaker 2: presence of 0.754 electron volts photons specifically modulates metabolic steps,
- 6:16Speaker 2: impacting ATP synthesis in a way consistent with the Marcus
- 6:19Speaker 2: electron transfer framework. Think of it as adjusting the vibrations. Fine.
- 6:24Speaker 2: Tuning the electron transfer chain to enhance or possibly inhibit
- 6:28Speaker 2: certain metabolic processes.
- 6:30Speaker 1: Got it. So... This isn't just about turning on a light.
- 6:34Speaker 1: It's about carefully tuning the light to resonate with the
- 6:37Speaker 1: right vibration frequencies, essentially coaxing the mitochondria to work at
- 6:42Speaker 1: higher or lower efficiencies. And this opens up a whole
- 6:46Speaker 1: new realm of possibilities in phototherapy, right?
- 6:49Speaker 2: Precisely. The implications for therapeutic applications are profound. Imagine targeting
- 6:55Speaker 2: specific metabolic disorders or even enhancing overall cellular function through
- 7:00Speaker 2: carefully controlled light exposure. It's a bit like using the
- 7:03Speaker 2: right tool for the right job. But in this case,
- 7:06Speaker 2: that tool is light, tuned to interact with the body's
- 7:09Speaker 2: vibrational states.
- 7:11Speaker 1: Speaking of which, let's look forward. How might this deepen
- 7:14Speaker 1: our understanding of how sunlight functions as a source of
- 7:18Speaker 1: energy for life on Earth? After all, sunlight's broad spectrum
- 7:22Speaker 1: of wavelengths enables interactions with multiple vibrational modes in the
- 7:26Speaker 1: mitochondrial machinery. potentially scaling up across the entire biosphere.
- 7:31Speaker 2: That's a fascinating point. Schwelt et al. 's work suggests
- 7:35Speaker 2: that ambient sunlight provides sufficient flux to influence metabolic kinetics
- 7:40Speaker 2: across the biosphere. The hypothesis that lower vibrational light frequencies
- 7:45Speaker 2: can affect cell-level processes mirrors the broader solar spectrum's interaction.
- 7:51Speaker 2: It's like the sun is orchestrating an intricate dance of
- 7:54Speaker 2: energy transfer. And we are only beginning to understand the choreography.
- 7:58Speaker 1: Indeed. And as we continue to explore this, it's crucial
- 8:03Speaker 1: for researchers, medical professionals, and even lighting and technology innovators
- 8:08Speaker 1: to collaborate. This could lead to groundbreaking applications like targeted
- 8:13Speaker 1: phototherapy treatments that address specific health needs by modulating these
- 8:18Speaker 1: vibrational states. It's an exciting frontier in photobiology and therapeutics. Absolutely.
- 8:25Speaker 2: The key is in the specificity understanding which wavelengths and
- 8:29Speaker 2: what conditions lead to the most beneficial outcomes. The next
- 8:32Speaker 2: steps will be rigorous testing and validation, but the potential
- 8:36Speaker 2: to revolutionize how we view and harness light for health
- 8:40Speaker 2: is immense.
- 8:40Speaker 1: Right, so let's dig into the contentious debate around direct
- 8:44Speaker 1: versus indirect mechanisms of photobiomodulation. Traditional thinking often leaned on
- 8:49Speaker 1: the idea that light directly impacted mitochondrial function. But Schwelt
- 8:54Speaker 1: et al. are proposing something quite different.
- 8:57Speaker 2: Exactly. And it's fascinating because the indirect mechanism involves the
- 9:02Speaker 2: modulation of vibrational states. Specifically, they suggest that certain wavelengths
- 9:07Speaker 2: of infrared light can affect the vibrational modes of molecules
- 9:11Speaker 2: within the mitochondria, which in turn influences the electron transfer chain. Wait.
- 9:16Speaker 1: But how does that differentially affect ATP production? It's not
- 9:20Speaker 1: like a one-size-fits-all solution. Is it?
- 9:24Speaker 2: No, it's much more nuanced. For instance, certain frequencies could
- 9:28Speaker 2: activate pathways that boost ATP synthesis while others might hinder it.
- 9:33Speaker 2: It's really about finding the right harmony between the wavelengths
- 9:36Speaker 2: to achieve the desired physiological outcomes.
- 9:39Speaker 1: And this approach has significant implications for scalability. Can we
- 9:43Speaker 1: apply this understanding across various scales, from individual cells to
- 9:48Speaker 1: entire organisms?
- 9:50Speaker 2: Absolutely. The metabolic scaling analysis suggests that ambient sunlight provides
- 9:55Speaker 2: the necessary photon flux to influence metabolic kinetics. So, theoretically,
- 10:00Speaker 2: this could have broad applications from therapies for metabolic disorders
- 10:04Speaker 2: to even potential environmental health benefits.
- 10:07Speaker 1: That's wild when you look at the raw numbers. But
- 10:10Speaker 1: how do we practically integrate this into clinical applications? What
- 10:14Speaker 1: kind of devices or treatments could emerge from this research?
- 10:17Speaker 2: Exactly. The next steps will be developing targeted phototherapy devices
- 10:22Speaker 2: that can modulate specific wavelengths to achieve desired effects on
- 10:26Speaker 2: mitochondrial function, perhaps wearable devices or even lighting systems that
- 10:31Speaker 2: optimize the spectrum to benefit users in various settings.
- 10:34Speaker 1: And who would benefit most from these advancements? It sounds
- 10:39Speaker 1: like a lot of potential stakeholders.
- 10:42Speaker 2: Photobiomodulation researchers and practitioners, medical professionals, lighting and technology innovators,
- 10:49Speaker 2: and even astrophysicists could all play significant roles. This research
- 10:53Speaker 2: could eventually lead to revolutionary treatments for a wide range
- 10:57Speaker 2: of conditions, from aging to metabolic disorders.
- 11:00Speaker 1: It's an exciting frontier for sure. But as we move forward,
- 11:04Speaker 1: we need to continue validating these hypotheses through rigorous testing
- 11:08Speaker 1: and clinical trials. To restill so much we don't fully
- 11:11Speaker 1: understand about the underlying mechanisms. Absolutely.
- 11:15Speaker 2: The key is collaboration across these different disciplines. Bringing together
- 11:20Speaker 2: the expertise of photobiologists, mitochondrial specialists, and even technologists could
- 11:26Speaker 2: lead to groundbreaking discoveries and therapies.
- 11:29Speaker 1: So, let's delve into the key quotes and unanswered questions
- 11:33Speaker 1: from the researchers. Dr. Swelt emphasized the importance of molecular vibrations.
- 11:39Speaker 1: But what does that mean for our understanding of metabolic disorders?
- 11:43Speaker 2: Right, because if we can manipulate these vibrations to enhance
- 11:47Speaker 2: ATP synthesis, it could potentially open up new avenues for
- 11:51Speaker 2: treating conditions like mitochondrial disease. It's a bit like tuning
- 11:55Speaker 2: an intricate piece of machinery to make it perform at
- 11:57Speaker 2: its best. What are the nuances we need to consider here?
- 12:01Speaker 1: Exactly, which brings up an interesting contradiction. The researchers suggest
- 12:06Speaker 1: an indirect interaction vibrational states rather than direct receptor activation.
- 12:12Speaker 1: How does that fit with the traditional PBM model where
- 12:14Speaker 1: light is thought to directly impact mitochondrial function?
- 12:18Speaker 2: That's the crux of the matter. It challenges the established
- 12:21Speaker 2: understanding and could have profound implications. For instance, if the
- 12:26Speaker 2: key mechanism is indirect, how does this impact the design
- 12:30Speaker 2: of phototherapy devices? We need to ensure these devices are
- 12:34Speaker 2: precise enough to modulate the right frequencies.
- 12:36Speaker 1: And Turi, still so much we don't know. How do
- 12:39Speaker 1: specific vibrational modes within the mitochondria affect the electron transfer chain?
- 12:45Speaker 1: This is a huge unanswered question. It's like trying to
- 12:49Speaker 1: understand a complex system without all the pieces of the puzzle. Absolutely.
- 12:54Speaker 1: And this opens up exciting possibilities. For example, Could ambient
- 12:58Speaker 1: sunlight provide enough flux to influence metabolic kinetics in humans?
- 13:03Speaker 1: That would shift our thinking about how we could use
- 13:05Speaker 1: light to improve health in a broader sense.
- 13:08Speaker 2: And it's not just about medical applications. Imagine how this
- 13:12Speaker 2: could impact the design of lighting in offices or homes.
- 13:16Speaker 2: Specially designed light could optimize people's health without the need
- 13:20Speaker 2: for expensive devices. The potential implications are vast.
- 13:24Speaker 1: That's wild when you look at the raw numbers. We
- 13:27Speaker 1: are talking about scaling effects across the biosphere. The metabolic
- 13:31Speaker 1: scaling analysis suggests sunlight may be a key player in
- 13:35Speaker 1: energy metabolism. This could change our view of how organisms
- 13:39Speaker 1: adapt to their environment.
- 13:41Speaker 2: Exactly. And it sets the stage for future advancements. Whether
- 13:45Speaker 2: we can harness this knowledge to develop targeted phototherapy for
- 13:49Speaker 2: metabolic disorders or to simply optimize our daily light exposure,
- 13:54Speaker 2: the possibilities are endless. This is where the rubber meets
- 13:57Speaker 2: the road, so to speak.
- 13:59Speaker 1: So, as we step back, what does this mean for
- 14:02Speaker 1: the broader integration into biophysical models and potential therapeutic implications?
- 14:08Speaker 1: It's clear the traditional views on PBM are shifting. But
- 14:12Speaker 1: how exactly do we translate this into actionable research?
- 14:15Speaker 2: Right. And that's the crucial nuance here. We need to
- 14:19Speaker 2: think of these models as a collaborative effort. blending traditional
- 14:23Speaker 2: notions of energy transfer with the innovative ideas from Schwelt
- 14:26Speaker 2: and his team. For instance, if specific wavelengths of light
- 14:30Speaker 2: can modulate metabolic steps, could we start designing phototherapy modalities
- 14:36Speaker 2: that target these steps directly?
- 14:38Speaker 1: Exactly, which brings up an interesting contradiction. On one hand,
- 14:43Speaker 1: the traditional view of PBM seemed to focus on direct
- 14:47Speaker 1: activation of receptors. Now, we are looking at an indirect
- 14:51Speaker 1: mechanism through vibrational states. How do we reconcile these perspectives?
- 14:57Speaker 2: Wait, but how does that actually play out in practice?
- 15:00Speaker 2: For example, if we can manipulate the vibrational modes to
- 15:03Speaker 2: enhance ATP production, we might see improvements in metabolic disorders
- 15:08Speaker 2: like fatigue or even certain neurological conditions. But we need
- 15:12Speaker 2: to establish a clear causal link first.
- 15:15Speaker 1: That's wild when you look at the raw numbers. If
- 15:17Speaker 1: ambient sunlight can influence metabolic kinetics, it could have profound
- 15:21Speaker 1: implications for both chronic disease management and even performance enhancement.
- 15:26Speaker 1: The metabolic scaling analysis suggests this flux is significant enough
- 15:29Speaker 1: to see effects at the organismal level. Right? I agree.
- 15:33Speaker 1: The key is to validate these hypotheses through rigorous multifaceted studies.
- 15:38Speaker 1: We need to explore both the direct and indirect mechanisms.
- 15:42Speaker 1: and see if we can engineer light with specific wavelengths
- 15:45Speaker 1: to target metabolic steps precisely. It's a bit like tuning
- 15:49Speaker 1: an instrument, but in this case, it's about tuning the
- 15:52Speaker 1: body's energy production.
- 15:54Speaker 2: Right. And it's not just about the technology. We also
- 15:57Speaker 2: need to consider the broader health implications. For medical professionals,
- 16:01Speaker 2: this could mean new approaches to treating disorders by adjusting
- 16:05Speaker 2: light exposure or even developing phototherapy devices. For lighting and
- 16:09Speaker 2: technology innovators, it opens up new fields of application.
- 16:13Speaker 1: Exactly. These insights could also be incorporated into broader biophysical models,
- 16:18Speaker 1: giving us a more nuanced understanding of how the environment
- 16:22Speaker 1: interacts with our bodies on a fundamental level. It's not
- 16:26Speaker 1: just about the light, but how those photons interact with
- 16:29Speaker 1: the vibrational dynamics of the cell.
- 16:32Speaker 2: Precisely. The next step is to gather more empirical data
- 16:36Speaker 2: through clinical trials and lab studies. If we can back
- 16:40Speaker 2: these hypotheses with solid evidence, we could see transformative changes
- 16:44Speaker 2: in how we approach energy metabolism and even develop novel therapies. True.
- 16:49Speaker 1: The path ahead is full of exciting possibilities, but also challenges.
- 16:54Speaker 1: We need a collaborative effort to refine our understanding and
- 16:58Speaker 1: translate it into practical benefits. It's an ambitious goal, but
- 17:02Speaker 1: one that could redefine our approach to health and wellness.
- 17:06Speaker 1: That brings us to the end of today's episode. Thank
- 17:08Speaker 1: you so much for spending part of your day with me.
- 17:11Speaker 1: If you found this episode's tips helpful and want to
- 17:14Speaker 1: make sure you don't miss the next conversation, please take
- 17:17Speaker 1: a quick second to hit that subscribe or follow button
- 17:20Speaker 1: on whatever platform you are listening on. It's a completely
- 17:23Speaker 1: free way to support the show and helps more people
- 17:26Speaker 1: find us. This podcast is independently produced, so if you
- 17:30Speaker 1: are ever in a position where you would like to
- 17:32Speaker 1: help keep it running, we do accept small donations. You
- 17:36Speaker 1: can find a link right in the episode description below.
- 17:38Speaker 1: to buy us a coffee, or contribute what you can.
- 17:42Speaker 1: Every bit genuinely helps. Take care of yourself, stay balanced,
- 17:46Speaker 1: and we will talk again soon.